㳿 ..

³    Facebook

 

:

,

,

,

,

,

- ,

:

:

" " (),
" " (),
" " ()
"&ճ"
()

:

,

:

, ,
,
,

:

:

-

ϳ :

,

,

,
,

:

', ,

:

, ,  

:

,

:


26.552.01:

2020 - 4.
̲ / / CONTENTS

 

в -ί ֲ / PROCEEDINGS OF THE CONFERENCE

 

DOI: 10.31215/2306-4927-2020-110-4-6-9
. .
COVID-19

A. Y. Dziublyk
MANAGEMENT OF COPD PATIENTS IN A COVID-19 PANDEMIC
 

DOI: 10.31215/2306-4927-2020-110-4-10-11
. .
COVID-19: ֲ?

M. M. Ostrovsky
COPD AND COVID-19: HOW TO PROTECT THE PATIENT?
 

 

DOI: 10.31215/2306-4927-2020-110-4-12-14
. .
ϲ Ͳ COVID-19: ѲͲ

Y. O. Dziublyk
COMMUNITY-ACQUIRED PNEUMONIA AND COVID-19: DISCUSSION ISSUES
 

DOI: 10.31215/2306-4927-2020-110-4-15-18
. .
- -2019

V. K. Gavrysyuk
CT-SEMIOTICS OF LUNG INVOLVEMENT IN COPD AND CORONAVIRUS DISEASE-2019
 

DOI: 10.31215/2306-4927-2020-110-4-19-20
. .
Ҳ ֲ ˲ ֲ ˲

T. O. Pertseva
THE ROLE OF QUALITY OF INGALATION OF MEDICINAL PRODUCT BY COPD PATIENTS IN MODERN REALITIES
 

DOI: 10.31215/2306-4927-2020-110-4-21-23
. . , . . ѳ
Ͳ ˲ : Ҳ?

Y. M. Mostovoy, A. A. Sidorov
COMPLIANCE WITH COPD TREATMENT: HOW TO ACHIEVE AND WHAT IS A RESULT?
 

 

DOI: 10.31215/2306-4927-2020-110-4-24-26
. .
ò Բ

M. M. Ostrovsky
STRATEGIES FOR PREVENTION AND MANAGEMENT OF EXACERBATION OF COPD
 

DOI: 10.31215/2306-4927-2020-110-4-27-29
. . , . . , . .
ί ί ˲ί ϲ : ̲ ˲ ò ˲

Y. M. Mostovoy, K. D. Dmytriev, N. S. Slepchenko
INFLUENCE OF BASIC COMBINED BRONCHOLYTIC THERAPY ON THE COURSE OF COPD: RESULTS OF INTERNATIONAL RESEARCH AND REGIONAL SUBANALYSIS
 

DOI: 10.31215/2306-4927-2020-110-4-30-32
. .
: IJ?

M. M. Ostrovsky
SYMPTOMS AND EXACERBATION IN COPD: TO WAIT OR TO ACT?
 

DOI: 10.31215/2306-4927-2020-110-4-33-35
. .
ϲ Ͳ : ͪ

K. Y. Gashinova
THERAPY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A LOOK INTO THE FUTURE
 

DOI: 10.31215/2306-4927-2020-110-4-36-40
. .
: ,

L. V. Yudina
ANTIMICROBIAL THERAPY OF COPD INFECTIOUS EXACERBATION: INDICATIONS, SELECTION OF THE DRUG
 

DOI: 10.31215/2306-4927-2020-110-4-41-42
. .
² ί ˲ί ϲ . Բֲ ?

M. M. Ostrovsky
NEW HORIZONS OF MODERN MUCOLYTIC THERAPY OF COPD. IS IT POSSIBLE TO ACHIEVE MODIFICATIONS OF THE COURSE?

 

 

DOI: 10.31215/2306-4927-2020-110-4-43-44
. .
ֲ Ͳ

Y. O. Dziublyk
INFECTIOUS EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 

DOI: 10.31215/2306-4927-2020-110-4-45-48
. .
Ͳ ղ : ̲ ز ֲ IJ ?

L. I. Konopkina
CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIAL ASTHMA: HAVE OUR VIEWS ON DIFFERENTIAL DIAGNOSIS CHANGED?

 

Ͳ IJ ˲ OVID-19 / TOPICAL ISSUES OF DIAGNOSIS AND TREATMENT OF OVID-19

 

DOI: 10.31215/2306-4927-2020-110-4-49-55
. . , . .
COVID-19-ֲ ϲ Ͳ: ˲Ͳ ² ů ˲Ͳ

Y. O. Dziublyk, L. V. Panchenko
COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA: CLINICAL EXPERIENCE OF PARENTERAL USE OF ACETYLCYSTEINE IN COMPLEX THERAPY

 

 

òͲ Ҳ / ORIGINALS

 

DOI: 10.31215/2306-4927-2020-110-4-56-60
. . , . . , . . , . . , . . ,. . , . . , . . , . .
˲ ֲ ϲֲ ղò ˲Ͳ ̲Ͳ

M. S. Opanasenko, V. I. Lysenko, O. V. Tereshkovich, B. M. Konik, M. I. Kalinichenko, L. I. Levanda, M. Yu. Shamrai, S. M. Shalagai, S. M. Belokon
ANALYSIS OF THE CAUSES OF THE MOST FREQUENT INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS IN THE SURGICAL TREATMENT OF PULMONARY AND PLEURAL TUBERCULOSIS USING MINIMALLY INVASIVE
INTERVENTIONS

 

DOI: 10.31215/2306-4927-2020-110-4-61-65
. . , . .
̲Ͳ ò ֲ в ٲ ֲ ί ҲҲ ̲в

O. A. Zhurilo, A. I. Barbova
USE OF THE METHOD FOR DETERMINING MINIMUM INHIBITORY CONCENTRATIONS IN A LIQUID MEDIA FOR SUSCEPTIBILTY TESTING OF NON-TUBERCULOSIS MYCOBACTERIA

 

ֲ / INFORMATION

 

, ²в ˲ ̲ (19362020)

PROFESSOR VICTORIA PAVLIVNA KOSTROMINA (1936-2020)
 

в / HISTORY OF MEDICINE

 

DOI: 10.31215/2306-4927-2020-110-4-67-72
. . , . . , . . ˳, . .
в ò ˲ ̲

O. V. Syniachenko, M. V. Iermolaeva, K. V. Liventsova, S. M. Verzilov
HISTORY OF PULMONOLOGY IN THE MIRROR OF NUMISMATICS

 

 

 


Home
ϳ  
I


, , Ͳ , .
'!

³
Ͳ

 E-mail

www.ifp.kiev.ua